X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3980) 3980
Publication (199) 199
Newsletter (97) 97
Book Review (41) 41
Newspaper Article (30) 30
Book Chapter (14) 14
Magazine Article (13) 13
Transcript (10) 10
Trade Publication Article (4) 4
Conference Proceeding (2) 2
Dissertation (2) 2
Paper (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
colchicine (2198) 2198
humans (1845) 1845
animals (1726) 1726
male (1697) 1697
colchicine - pharmacology (1146) 1146
female (1084) 1084
index medicus (1062) 1062
rats (1011) 1011
colchicine - administration & dosage (868) 868
colchicine - therapeutic use (783) 783
adult (559) 559
middle aged (517) 517
pharmacology & pharmacy (413) 413
mice (403) 403
aged (324) 324
neurosciences (313) 313
treatment outcome (308) 308
time factors (304) 304
familial mediterranean fever (292) 292
rheumatology (286) 286
dose-response relationship, drug (284) 284
gout (273) 273
colchicine - adverse effects (266) 266
care and treatment (256) 256
rats, inbred strains (242) 242
gout - drug therapy (236) 236
therapy (232) 232
analysis (213) 213
medicine, general & internal (210) 210
rats, sprague-dawley (208) 208
familial mediterranean fever - drug therapy (206) 206
research (203) 203
drug therapy, combination (180) 180
drug therapy (179) 179
gout suppressants - therapeutic use (179) 179
immunohistochemistry (178) 178
rats, wistar (176) 176
dosage and administration (174) 174
inflammation (174) 174
microtubules - drug effects (163) 163
management (160) 160
toxicology (160) 160
administration, oral (156) 156
biochemistry & molecular biology (155) 155
gout suppressants - administration & dosage (154) 154
adolescent (153) 153
cancer (151) 151
medicine & public health (149) 149
cardiac & cardiovascular systems (148) 148
tubulin (148) 148
double-blind (147) 147
health aspects (147) 147
rat (146) 146
diagnosis (143) 143
arthritis (141) 141
colchicine - toxicity (137) 137
microtubules (134) 134
cell biology (130) 130
amyloidosis (129) 129
drugs (129) 129
prevention (129) 129
anti-inflammatory agents, non-steroidal - therapeutic use (128) 128
risk factors (126) 126
disease (124) 124
apoptosis (123) 123
oncology (123) 123
child (121) 121
follow-up studies (121) 121
acute disease (120) 120
recurrence (119) 119
abridged index medicus (118) 118
tubulin - metabolism (117) 117
microscopy, electron (115) 115
toxicity (115) 115
cells (114) 114
liver - metabolism (114) 114
internal medicine (112) 112
cells, cultured (109) 109
drug administration schedule (109) 109
tubulins (108) 108
colchicine - analogs & derivatives (106) 106
colchicine - pharmacokinetics (105) 105
mitosis - drug effects (105) 105
liver - drug effects (104) 104
dermatology (101) 101
liver (101) 101
expression (99) 99
anti-inflammatory agents - therapeutic use (98) 98
chemistry, medicinal (98) 98
disease models, animal (98) 98
colchicine - metabolism (97) 97
in vitro techniques (97) 97
medicine (96) 96
brain (95) 95
usage (95) 95
antineoplastic agents - pharmacology (94) 94
medical research (94) 94
neurons (94) 94
inhibition (93) 93
neurons - drug effects (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3885) 3885
French (89) 89
Japanese (50) 50
German (48) 48
Russian (41) 41
Spanish (20) 20
Italian (14) 14
Chinese (7) 7
Polish (6) 6
Danish (5) 5
Korean (3) 3
Czech (2) 2
Turkish (2) 2
Bulgarian (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 12/2014, Volume 53, Issue 12, pp. 2167 - 2174
Journal Article
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2017, Volume 76, Issue Suppl 2, p. 370
BackgroundVerinurad (RDEA3170) is a novel selective uric acid reabsorption inhibitor in clinical development for the treatment of hyperuricemia and... 
Urine | EKG | Pharmacodynamics | Excretion | Laboratories | Allopurinol | Gout | Reabsorption | Uric acid | Hyperuricemia | Rheumatism | Drug interaction | Colchicine | Pharmacokinetics | Drug dosages
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 4, pp. 404 - 410
Objectives The objective of this study was to determine whether colchicine 0.5 mg/day can reduce the risk of cardiovascular events in patients with clinically... 
Cardiovascular | Internal Medicine | colchicine | secondary prevention | stable coronary disease | CARDIAC & CARDIOVASCULAR SYSTEMS | FAMILIAL MEDITERRANEAN FEVER | MYOCARDIAL-INFARCTION | CORONARY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Out-of-Hospital Cardiac Arrest - epidemiology | Intestinal Diseases - chemically induced | Humans | Out-of-Hospital Cardiac Arrest - etiology | Colchicine - administration & dosage | Coronary Disease - physiopathology | Male | Withholding Treatment - statistics & numerical data | Colchicine - adverse effects | Secondary Prevention - methods | Incidence | Brain Infarction - prevention & control | Canada - epidemiology | Coronary Disease - complications | Endpoint Determination | Tubulin Modulators - administration & dosage | Female | Drug Therapy, Combination | Tubulin Modulators - adverse effects | Acute Coronary Syndrome - epidemiology | Risk Assessment | Proportional Hazards Models | Treatment Outcome | Plaque, Atherosclerotic - etiology | Plaque, Atherosclerotic - physiopathology | Brain Infarction - etiology | Out-of-Hospital Cardiac Arrest - prevention & control | Brain Infarction - epidemiology | Acute Coronary Syndrome - etiology | Coronary Disease - drug therapy | Aged | Plaque, Atherosclerotic - drug therapy | Acute Coronary Syndrome - prevention & control | Dosage and administration | Colchicine | Cardiovascular diseases | Cardiology | Heart attack | Coronary heart disease | Heart attacks | Heart surgery | Medical services | Prevention | Confidence intervals | Motivation | Ischemia | Consent | Intestine | Atherosclerosis | Drug dosages | Plaques | Statins | Aspirin | Stroke | Stability | Health risks | Risk reduction | Leukocytes (neutrophilic) | Patients | Disease prevention | Intolerance | Arteriosclerosis | Clopidogrel | Acute coronary syndromes
Journal Article